vancomycin has been researched along with dicloxacillin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hubmann, R | 1 |
| Fomina, IP; Kuznetsova, SM; Speranskaia, ON | 1 |
| Benner, EJ; Bennett, JV; Brodie, JL; Kirby, WM | 1 |
| Archer, G; Bornholm, J; Yu, VL; Zuravleff, JJ | 1 |
| Erlendsdóttir, H; Gottfredsson, M; Gudmundsson, A; Gudmundsson, S | 1 |
| Agrawal, M; Bhat, N; Dhawan, VK; Nachum, R; Tolbert, L | 1 |
| Azeredo, J; Cerca, N; Henriques, M; Oliveira, R | 1 |
| Leaños-Miranda, BE; Miranda-Novales, G; Solórzano-Santos, F; Vilchis-Pérez, M | 1 |
| Ikonomidis, A; Karavasilis, V; Labrou, M; Maniatis, AN; Michail, G; Pournaras, S; Stathopoulos, C; Vasdeki, A | 1 |
| Berisa, AE; Georgoulis, AD; Lykissas, MG; Manoudis, GN; Mitsionis, GI; Motsis, E; Sionti, I | 1 |
| Labrou, M; Michail, G; Ntokou, E; Pittaras, TE; Pournaras, S; Tsakris, A | 1 |
| Bushrow, L; Calhoun, JH; Dusane, DH; Granger, JF; Kyrouac, D; Petersen, I; Phieffer, LS; Stoodley, P | 1 |
1 review(s) available for vancomycin and dicloxacillin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for vancomycin and dicloxacillin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
[Elimination of antibiotics and sulfonamides from the human organism during renal insufficiency and the therapeutic consequences].
Topics: Ampicillin; Anti-Bacterial Agents; Cephaloridine; Cephalothin; Chloramphenicol; Creatinine; Dicloxacillin; Gentamicins; Humans; Kanamycin; Kidney Diseases; Methicillin; Novobiocin; Oxacillin; Penicillin G; Penicillins; Polymyxins; Streptomycin; Sulfonamides; Tetracycline; Vancomycin | 1969 |
[Methicillin-resistant staphylococci: biological properties and sensitivity to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephaloridine; Chloramphenicol; Dicloxacillin; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Methicillin; Oxacillin; Penicillin G; Penicillin Resistance; Penicillinase; Rifampin; Staphylococcus; Streptomycin; Tetracycline; Vancomycin | 1973 |
Simplified, accurate method for antibiotic assay of clinical specimens.
Topics: Ampicillin; Anti-Bacterial Agents; Bacillus subtilis; Bacteriological Techniques; Bordetella; Cephaloridine; Cephalothin; Cloxacillin; Colistin; Culture Media; Dicloxacillin; Humans; Kanamycin; Methicillin; Nafcillin; Oxacillin; Penicillin G; Penicillins; Sarcina; Tetracycline; Vancomycin | 1966 |
In-vitro synergy testing of triple antibiotic combinations against Staphylococcus epidermidis isolates from patients with endocarditis.
Topics: Anti-Bacterial Agents; Dicloxacillin; Drug Combinations; Drug Synergism; Endocarditis, Bacterial; Fusidic Acid; Gentamicins; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcus epidermidis; Vancomycin | 1984 |
Different patterns of bacterial DNA synthesis during postantibiotic effect.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dicloxacillin; DNA, Bacterial; Escherichia coli; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tobramycin; Vancomycin | 1995 |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Bisexuality; Black People; Cephalexin; Cephalosporins; Clarithromycin; Dicloxacillin; Doxycycline; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Homosexuality, Male; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; White People | 1998 |
Influence of sub-inhibitory concentrations of antimicrobial agents on biofilm formation in indwelling medical devices.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida; Cefazolin; Dicloxacillin; Fluconazole; Humans; Staphylococcus epidermidis; Vancomycin | 2005 |
In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cephalothin; Dicloxacillin; Drug Synergism; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin | 2006 |
In vitro and in vivo evaluations of oxacillin efficiency against mecA-positive oxacillin-susceptible Staphylococcus aureus.
Topics: Animals; Bacterial Proteins; Dicloxacillin; Genes, Bacterial; Humans; Male; Methicillin Resistance; Mice; Oxacillin; Penicillin Resistance; Penicillin-Binding Proteins; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Pyomyositis in children: early diagnosis and treatment.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Combined Modality Therapy; Dicloxacillin; Drainage; Early Diagnosis; Female; Humans; Magnetic Resonance Imaging; Male; Muscle, Skeletal; Pyomyositis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2009 |
Activity of oxacillin versus that of vancomycin against oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates evaluated by population analyses, time-kill assays, and a murine thigh infection model.
Topics: Animals; Anti-Bacterial Agents; Dicloxacillin; Female; Mice; Mice, Inbred BALB C; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Thigh; Vancomycin | 2012 |
Targeting intracellular Staphylococcus aureus to lower recurrence of orthopaedic infection.
Topics: Alkaloids; Anti-Bacterial Agents; Benzodioxoles; Bone Morphogenetic Protein 2; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Line, Tumor; Dicloxacillin; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Host-Pathogen Interactions; Humans; Microbial Sensitivity Tests; Osteoblasts; Osteomyelitis; Piperidines; Polyunsaturated Alkamides; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2018 |